---
title: ARISE: An adaptive residual-informed stability ensemble for feature selection in small-sample biomedical omics
url: http://arxiv.org/abs/2608.14866v1
type: paper-summary
date: 2026-08-17
source_paper: 2026-08-14_20-10-22Z_ARISE_Anadaptiveresidual_informedstabilityensemble.md
generated_at: 2026-08-17 21:42
model: nvidia/nemotron-3-nano-4b
---

## Summary
The paper introduces ARISE, an adaptive residual-informed stability ensemble that selects predictive, stable, nonredundant features in small-sample biomedical omics classification. It outperforms existing methods across 15 dataset-metric combinations with balanced accuracy, macro-F1, and Cohen's kappa gains of up to 0.028.

## Key Takeaways
- ARISE integrates seven percentile-normalized relevance components into 15 predefined profiles, adaptively weighted by nested inner cross-validation, achieving top ranking in all assessments.
- The ensemble’s balanced accuracy mean (0.793) exceeds the strongest aggregate comparator by 0.022, demonstrating superior stability and predictive power.
- Performance remains robust across compact feature sets despite varying optimal budgets per dataset.

## Context
Small-sample molecular classification suffers from limited data leading to unstable feature selection and high variance in classifiers. Traditional methods often prioritize relevance without considering redundancy or multiclass coverage, resulting in suboptimal generalisation. ARISE addresses these gaps by jointly evaluating relevance, stability, redundancy, and pairwise discrimination.

## Implications
For researchers working with rare disease biomarkers, ARISE offers a transparent pipeline to choose reliable feature subsets, reducing false positives and improving diagnostic accuracy. Clinicians can rely on ensembles that balance predictive power with interpretability, supporting evidence‑based decision making in resource‑constrained settings.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2608.14866v1)
